Simulation of the Dosing Regimen of the Anti-MRSA Drug Daptomycin in a Patient Receiving Thrice-weekly Hemodialysis: Is It Reasonable to Administer 1.5 Times Dosage before the 72-hour Interval after Dialysis?-Reference-Cited by-同舟云学术

Simulation of the Dosing Regimen of the Anti-MRSA Drug Daptomycin in a Patient Receiving Thrice-weekly Hemodialysis: Is It Reasonable to Administer 1.5 Times Dosage before the 72-hour Interval after Dialysis?

Published:2020-11-30 Issue:6 Volume:51 Page:325-330
ISSN:0388-1601
Container-title:Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
language:en
Short-container-title:Jpn. J. Clin. Pharmacol. Ther.

Author:

ABE Junko¹,YAMADA Koichi¹²,YOSHII Naoko¹²,SHIBATA Wataru¹²,OSHIMA Kazuhiro¹²,KAKEYA Hiroshi¹²

Affiliation:

1. Department of Infection Control Science, Graduate School of Medicine, Osaka City University, Japan

2. Department of Infection Control and Prevention, Osaka City University Hospital, Japan

Publisher

Japanese Society of Clinical Pharmacology and Therapeutics

Subject

Pharmacology (medical),Pharmacology

Link

https://www.jstage.jst.go.jp/article/jscpt/51/6/51_325/_pdf

Reference15 articles.

1. 3) THE SANFORD GUIDE To Antimicrobial Therapy 2019, 49^thEd. 2019．

2. 4) Butterfield JM, Mueller BA, Patel N, Cardone KE, Grabe DW, Salama NN, et al. Daptomycin pharmacokinetics and pharmacodynamics in a pooled sample of patients receiving thrice-weekly haemodialysis. Antimicrob Agents Chemother. 2013; 57 (2): 864-72. doi: 10.1128/AAC.02000-12.

3. 5) Patel N, Cardone K, Grabe DW, Meola S, Hoy C, Manley H, et al. Use of pharmacokinetic and pharmacodynamic principles to determine optimal administration of daptomycin in patients receiving standardized thrice-weekly hemodialysis. Antimicrob Agents Chemother. 2011; 55 (4): 1677-83. doi: 10.1128/AAC.01224-10.

4. 6) Haselden M, Leach M, Bohm N. Daptomycin dosing strategies in patients receiving thrice-weekly intermittent hemodialysis. Ann Pharmacother. 2013; 47(10): 1342-7. doi: 10.1177/1060028013503110.

5. 7) Siala W, Mingeot-Leclercq MP, Tulkens PM, Hallin M, Denis O, Van Bambeke F. Comparison of the antibiotic activities of daptomycin, vancomycin, and the investigational fluoroquinolone delafloxacin against biofilms from Staphylococcus aureus clinical isolates. Antimicrob Agents Chemother. 2014; 58 (11): 6385-97. doi: 10.1128/AAC.03482-14.